Stock Notes

Granules India

Every Finvezto stock note on Granules India, dated and newest first. Coverage spans pharma.

1 note and counting
06 Jul 2026
Granules India secured sole first-to-file ANDA status for sodium oxybate extended-release for oral suspension.
First-to-file gives a period of US marketing exclusivity, and this is a high-value, hard-to-make product. It lifts the US specialty pipeline.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.